What's new

Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (previously Rivaroxaban Mylan), rivaroxaban, Date of authorisation: 12/11/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (previously Rivaroxaban Mylan), rivaroxaban, Date of authorisation: 12/11/2021, Revision: 7, Status: Authorised

Jun 4, 2025 - 16:20
 0
Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (previously Rivaroxaban Mylan), rivaroxaban, Date of authorisation: 12/11/2021, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (previously Rivaroxaban Mylan), rivaroxaban, Date of authorisation: 12/11/2021, Revision: 7, Status: Authorised
Read More

Tags:

Previous Article

PSUSA/00010855/202408

Next Article

Human medicines European public assessment report (EPAR): Spexotras, trametinib,...

Related Posts

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2025, 11:00 (CET) to 18 November 2025, 12:00 (CET)

Questions and answers clinic on Product Management Serv...

May 15, 2025  0

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - August 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 28 August 2025, 10:00 (CEST) to 28 August 2025, 11:00 (CEST)

Questions and answers clinic on Product Management Serv...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 4, 2025  0